Department of Cardiovascular Medicine, John Radcliffe Hospital, University of Oxford, UK.
Integr Biol (Camb). 2010 Oct;2(10):467-82. doi: 10.1039/c0ib00022a. Epub 2010 Sep 8.
Molecular imaging refers to the non-invasive visualisation of biological processes at the molecular and cellular levels within a living organism, and offers a wide range of potential benefits to both clinical medicine and research into novel therapeutic agents. Inflammation plays an important role in a wide variety of pathological processes and imaging the molecular and cellular machinery that underlies chronic inflammation is attractive and feasible. In this review, we present an overview of molecular imaging of inflammation. We start by characterising molecular and cellular events in early inflammation, identifying current and potential future imaging targets. We focus on the imaging of endothelial cells, which mediate the important first steps in inflammation in any tissue, are readily accessible to imaging probes and which present an approach that can be applied across multiple modalities. We then review the generic requirements for imaging contrast agents and focus on the important considerations in respect of ligands, ligand-target interactions and contrast vehicles. We aim to provide an integrated view of current progress with a focus on promising recent developments in experimental and translational molecular imaging.
分子成像指的是在活体内对分子和细胞水平的生物过程进行非侵入式可视化,它为临床医学和新型治疗药物的研究带来了广泛的潜在益处。炎症在多种病理过程中发挥着重要作用,对慢性炎症所涉及的分子和细胞机制进行成像具有吸引力且切实可行。在这篇综述中,我们介绍了炎症的分子成像。我们首先描述了早期炎症中的分子和细胞事件,确定了当前和潜在的未来成像靶点。我们专注于内皮细胞的成像,因为内皮细胞介导了任何组织中炎症的重要初始步骤,很容易被成像探针检测到,并且提供了一种可以应用于多种模态的方法。然后,我们回顾了成像对比剂的一般要求,并重点讨论了配体、配体-靶标相互作用和对比载体方面的重要考虑因素。我们旨在提供当前进展的综合视图,并重点关注实验和转化分子成像方面有前途的最新进展。